FY2025 EPS Estimates for Transcat Lowered by Northland Capmk

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Capmk lowered their FY2025 earnings per share (EPS) estimates for shares of Transcat in a note issued to investors on Wednesday, October 30th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $1.88 per share for the year, down from their previous forecast of $2.00. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat’s FY2027 earnings at $2.69 EPS and FY2028 earnings at $2.99 EPS.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.62%. The business had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. During the same period in the prior year, the company posted $0.41 earnings per share. The firm’s revenue was up 8.0% compared to the same quarter last year.

Several other research firms have also recently weighed in on TRNS. Craig Hallum reduced their target price on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research note on Wednesday. Northland Securities cut their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday. HC Wainwright reissued a “buy” rating and set a $156.00 price objective on shares of Transcat in a report on Tuesday. Oppenheimer restated an “outperform” rating and issued a $130.00 target price (down from $155.00) on shares of Transcat in a research note on Wednesday. Finally, StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $127.25.

Transcat Price Performance

Shares of Transcat stock opened at $95.57 on Friday. The company has a market cap of $874.47 million, a PE ratio of 48.27 and a beta of 0.67. The firm has a fifty day moving average price of $122.34 and a two-hundred day moving average price of $121.99. Transcat has a fifty-two week low of $84.45 and a fifty-two week high of $147.12.

Hedge Funds Weigh In On Transcat

Hedge funds and other institutional investors have recently modified their holdings of the stock. Diversified Trust Co raised its stake in Transcat by 23.6% during the first quarter. Diversified Trust Co now owns 3,010 shares of the scientific and technical instruments company’s stock worth $335,000 after acquiring an additional 575 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Transcat by 24.2% during the 1st quarter. BNP Paribas Financial Markets now owns 14,024 shares of the scientific and technical instruments company’s stock worth $1,563,000 after purchasing an additional 2,737 shares in the last quarter. Essex Investment Management Co. LLC increased its position in shares of Transcat by 1.5% during the 1st quarter. Essex Investment Management Co. LLC now owns 37,435 shares of the scientific and technical instruments company’s stock worth $4,171,000 after purchasing an additional 569 shares in the last quarter. Swiss National Bank lifted its holdings in Transcat by 1.2% during the 1st quarter. Swiss National Bank now owns 17,415 shares of the scientific and technical instruments company’s stock valued at $1,941,000 after purchasing an additional 200 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Transcat by 8.6% in the first quarter. Russell Investments Group Ltd. now owns 26,713 shares of the scientific and technical instruments company’s stock valued at $2,977,000 after buying an additional 2,121 shares in the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.